Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Company Data

Name Pasithea Therapeutics Corp. - Common Stock

Company Pasithea Therapeutics Corp.

Symbol KTTA

Website https://www.pasithea.com

Primary Exchange

NASDAQ

ISIN US70261F2020

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Tiago Reis Marques

Country United States of America

Currency USD

Employees 0,0 T

Address 1111 Lincoln Road, 33139 Miami Beach

IPO Date 2021-09-15

Ticker Symbols

Name	Symbol
NASDAQ	KTTA

More Shares

Investors who hold Pasithea Therapeutics Corp. - Common Stock also have the following shares in their portfolio:

NORDLB 24/37 Bond

WuHan Yangtze Communication Industry GroupCo.,Ltd Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog